{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:54:16Z","timestamp":1775465656300,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA046703"],"award-info":[{"award-number":["R21DA046703"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Opioid overdose fatalities are preventable with timely administration of naloxone, an opioid antagonist, during an opioid overdose event. Syringe service programs have pioneered naloxone distribution for potential bystanders of opioid overdose. The objective of this study was to pilot test a multi-component implementation strategy\u2014the systems analysis and improvement approach for naloxone (SAIA-Naloxone)\u2014with the goal of improving naloxone distribution by syringe service programs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two syringe service programs participated in a 6-month pilot of SAIA-Naloxone, which included (1) analyzing program data to identify gaps in the naloxone delivery cascade, (2) flow mapping to identify causes of attrition and brainstorm programmatic changes for improvement, and (3) conducting continuous quality improvement to test and assess whether modifications improve the cascade. We conducted an interrupted time series analysis using 52\u00a0weeks of data before and 26\u00a0weeks of data after initiating SAIA-Naloxone. Poisson regression was used to evaluate the association between SAIA-Naloxone and the weekly number of participants receiving naloxone and number of naloxone doses distributed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Over the course of the study, 11,107 doses of naloxone were distributed to 6,071 participants. Through SAIA-Naloxone, syringe service programs prioritized testing programmatic modifications to improve data collection procedures, proactively screen and identify naloxone-na\u00efve participants, streamline naloxone refill systems, and allow for secondary naloxone distribution. SAIA-Naloxone was associated with statistically significant increases in the average number of people receiving naloxone per week (37% more SPP participants; 95% CI, 12% to 67%) and average number of naloxone doses distributed per week (105% more naloxone doses; 95% CI, 79% to 136%) beyond the underlying pre-SAIA-Naloxone levels. These initial increases were extended by ongoing positive changes over time (1.6% more SSP participants received naloxone and 0.3% more naloxone doses were distributed in each subsequent week compared to the weekly trend in the pre-SAIA Naloxone period).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>SAIA-Naloxone has strong potential for improving naloxone distribution from syringe service programs. These findings are encouraging in the face of the worsening opioid overdose crisis in the United States and support testing SAIA-Naloxone in a large-scale randomized trial within syringe service programs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-09289-8","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T14:09:02Z","timestamp":1679494142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-8803","authenticated-orcid":false,"given":"Sheila V.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn D.","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex H.","family":"Kral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Sherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjuli D.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barrot H.","family":"Lambdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"9289_CR1","unstructured":"SAMHSA. Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2019 Contract No.: HHS Publication No. PEP19\u20135068, NSDUH Series H-54."},{"key":"9289_CR2","unstructured":"Alderks CE. Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003\u20132015 (Update). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2017.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK469748\/."},{"issue":"50\u201351","key":"9289_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","volume":"65","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Seth P, David F, Scholl L. Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2016;65(50\u201351):1445\u201352.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"9289_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson N, Kariisa M, Seth P, Smith H, Davis NL. Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018. MMWR Morbidity and mortality weekly report. 2020;69(11):290\u20137.","journal-title":"MMWR Morbidity and mortality weekly report."},{"key":"9289_CR5","first-page":"1","volume":"356","author":"H Hedegaard","year":"2020","unstructured":"Hedegaard H, Mini\u00f1o AM, Warner M. Drug Overdose Deaths in the United States, 1999\u20132018. NCHS Data Brief. 2020;356:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"6","key":"9289_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"9289_CR7","volume-title":"Wide-ranging online data for epidemiologic research (WONDER)","author":"CDC","year":"2020","unstructured":"CDC. Wide-ranging online data for epidemiologic research (WONDER). Atlanta: GA: National Center for Health Statistics, Centers for Disease Control and Prevention; 2020."},{"key":"9289_CR8","unstructured":"NIDA. Overdose Death Rates Bethesda, MD: National Institute on Drug Abuse; 2017 [cited 2017 September 24]. Available from: https:\/\/www.drugabuse.gov\/drug-topics\/trends-statistics\/overdose-death-rates."},{"issue":"6","key":"9289_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/0735-6757(94)90033-7","volume":"12","author":"JM Chamberlain","year":"1994","unstructured":"Chamberlain JM, Klein BL. A comprehensive review of naloxone for the emergency physician. Am J Emerg Med. 1994;12(6):650\u201360.","journal-title":"Am J Emerg Med"},{"issue":"10","key":"9289_CR10","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/acem.12485","volume":"21","author":"CS Davis","year":"2014","unstructured":"Davis CS, Southwell JK, Niehaus VR, Walley AY, Dailey MW. Emergency medical services naloxone access: a national systematic legal review. Acad Emerg Med Off J Soc Acad Emerg Med. 2014;21(10):1173\u20137.","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"issue":"6","key":"9289_CR11","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/S0002-9440(10)63747-9","volume":"164","author":"C Michiels","year":"2004","unstructured":"Michiels C. Physiological and pathological responses to hypoxia. Am J Pathol. 2004;164(6):1875\u201382.","journal-title":"Am J Pathol"},{"issue":"1","key":"9289_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40621-015-0041-8","volume":"2","author":"RE Giglio","year":"2015","unstructured":"Giglio RE, Li G, DiMaggio CJ. Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Inj Epidemiol. 2015;2(1):10.","journal-title":"Inj Epidemiol"},{"issue":"8","key":"9289_CR13","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.2105\/AJPH.2014.302062","volume":"104","author":"CS Davis","year":"2014","unstructured":"Davis CS, Ruiz S, Glynn P, Picariello G, Walley AY. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am J Public Health. 2014;104(8):e7-9.","journal-title":"Am J Public Health"},{"key":"9289_CR14","unstructured":"CDC. Syringe Service Programs (SSPs) Atlanta, GA: Centers for Disease Control and Prevention; 2019 [cited 2020 May 5]. Available from: https:\/\/www.cdc.gov\/ssp\/index.html."},{"key":"9289_CR15","volume-title":"Influence of state overdose laws and naloxone programs on opioid overdose mortality","author":"C McClellan","year":"2017","unstructured":"McClellan C, Lambdin BH, Ali MM, Mutter R, Davis CS, Wheeler E, et al. Influence of state overdose laws and naloxone programs on opioid overdose mortality. Atlanta: American Public Health Association; November; 2017."},{"key":"9289_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2017.11.017","volume":"52","author":"BH Lambdin","year":"2018","unstructured":"Lambdin BH, Zibbell J, Wheeler E, Kral AH. Identifying gaps in the implementation of naloxone programs for laypersons in the United States. Int J Drug Policy. 2018;52:52\u20135.","journal-title":"Int J Drug Policy"},{"key":"9289_CR17","unstructured":"Lambdin BH, Wenger LD, Bluthenthal RN, Garner B, LaKosky P, O'Neill S, et al. Understanding the influence of external and internal characteristics on the penetration of naloxone delivery from syringe service programs in the United States. 13th Annual Conference on the Science of Dissemination and Implementation in Health; December; Virtual\u00a02020."},{"key":"9289_CR18","doi-asserted-by":"publisher","first-page":"108759","DOI":"10.1016\/j.drugalcdep.2021.108759","volume":"225","author":"EN Kinnard","year":"2021","unstructured":"Kinnard EN, Bluthenthal RN, Kral AH, Wenger LD, Lambdin BH. The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco. CA Drug and alcohol dependence. 2021;225:108759.","journal-title":"CA Drug and alcohol dependence"},{"issue":"3","key":"9289_CR19","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1097\/QAI.0000000000001023","volume":"72","author":"AS Rustagi","year":"2016","unstructured":"Rustagi AS, Gimbel S, Nduati R, Cuembelo Mde F, Wasserheit JN, Farquhar C, et al. Implementation and Operational Research: Impact of a Systems Engineering Intervention on PMTCT Service Delivery in C\u00f4te d\u2019Ivoire, Kenya, Mozambique: A Cluster Randomized Trial. J Acquir Immune Defic Syndr (1999). 2016;72(3):e68-76.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"9289_CR20","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1097\/QAI.0000000000001055","volume":"72","author":"S Gimbel","year":"2016","unstructured":"Gimbel S, Rustagi AS, Robinson J, Kouyate S, Coutinho J, Nduati R, et al. Evaluation of a Systems Analysis and Improvement Approach to Optimize Prevention of Mother-To-Child Transmission of HIV Using the Consolidated Framework for Implementation Research. JAIDS J Acquired Immune Defic Syndr. 2016;72:S108\u201316.","journal-title":"JAIDS J Acquired Immune Defic Syndr"},{"issue":"2","key":"9289_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.annemergmed.2006.05.025","volume":"49","author":"KA Sporer","year":"2007","unstructured":"Sporer KA, Kral AH. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med. 2007;49(2):172\u20137.","journal-title":"Ann Emerg Med"},{"issue":"8","key":"9289_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3111\/13696998.2013.811080","volume":"16","author":"PO Coffin","year":"2013","unstructured":"Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities. J Med Econ. 2013;16(8):1051\u201360.","journal-title":"J Med Econ"},{"issue":"1","key":"9289_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1748-5908-9-55","volume":"9","author":"K Sherr","year":"2014","unstructured":"Sherr K, Gimbel S, Rustagi A, Nduati R, Cuembelo F, Farquhar C, et al. Systems analysis and improvement to optimize pMTCT (SAIA): a cluster randomized trial. Implement Sci. 2014;9(1):55.","journal-title":"Implement Sci"},{"issue":"Suppl 3","key":"9289_CR24","doi-asserted-by":"publisher","first-page":"S322","DOI":"10.1097\/QAI.0000000000002220","volume":"82","author":"AD Wagner","year":"2019","unstructured":"Wagner AD, Gimbel S, \u00c1sbj\u00f6rnsd\u00f3ttir KH, Cherutich P, Coutinho J, Crocker J, et al. Cascade Analysis: An Adaptable Implementation Strategy Across HIV and Non-HIV Delivery Platforms. J Acquir Immune Defic Syndr (1999). 2019;82(Suppl 3):S322-s31.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"9289_CR25","unstructured":"Lambdin BH, Wenger L, Kral AH, Wagner AD, Sherr K. Optimizing naloxone distribution to prevent opioid overdose fatalities: Results from piloting the systems analysis and improvement approach within syringe service programs. 13th Annual Conference on the Science of Dissemination and Implementation in Health; December; Virtual\u00a02020."},{"issue":"2","key":"9289_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/BF02287706","volume":"29","author":"PG Stiles","year":"2002","unstructured":"Stiles PG, Boothroyd RA, Snyder K, Zong X. Service penetration by persons with severe mental illness: how should it be measured? J Behav Health Serv Res. 2002;29(2):198\u2013207.","journal-title":"J Behav Health Serv Res"},{"key":"9289_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1748-5908-8-139","volume":"8","author":"EK Proctor","year":"2013","unstructured":"Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implementation science\u202f: IS. 2013;8:139.","journal-title":"Implementation science : IS"},{"key":"9289_CR28","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.","journal-title":"BMJ"},{"issue":"10169","key":"9289_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(18)33065-4","volume":"393","author":"SM Bird","year":"2019","unstructured":"Bird SM, McAuley A. Scotland\u2019s National Naloxone Programme. Lancet. 2019;393(10169):316\u20138.","journal-title":"Lancet"},{"issue":"1","key":"9289_CR30","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348\u201355.","journal-title":"Int J Epidemiol"},{"key":"9289_CR31","unstructured":"Lambdin BH, Wenger L, Bluthenthal RN, Tookes H, P. L, T. M, et al. Understanding the impact of COVID-19 on the penetration of naloxone distribution from syringe service programs in the United States. 14th Annual Conference on the Science of Dissemination and Implementation in Health; December; Virtual\u00a02021."},{"issue":"6","key":"9289_CR32","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1093\/ije\/dyy135","volume":"47","author":"J Lopez Bernal","year":"2018","unstructured":"Lopez Bernal J, Cummins S, Gasparrini A. The use of controls in interrupted time series studies of public health interventions. Int J Epidemiol. 2018;47(6):2082\u201393.","journal-title":"Int J Epidemiol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09289-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-09289-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09289-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T14:17:19Z","timestamp":1679494639000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-09289-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9289"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-09289-8","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study procedures were reviewed and approved by the RTI International Office of Research Protection Institutional Review Board (STUDY00020144). Leaders and staff at the pilot organizations consented to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}